Research study Program year 2022 Source: CMS Open Payments

Acp-044-004

ClinicalTrials.gov NCT04855240

Research payments

$2,579,610

42 payments

Through program year 2022, $2,579,610 in research payments was reported against Acp-044-004, across 42 payments, paid by ACADIA Pharmaceuticals Inc.

Paid by: ACADIA Pharmaceuticals Inc
ClinicalTrials.gov: NCT04855240

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$390,128	11
2021	Research	$2,189,482	31

Breakdown

Who paid Research payments · program years 2021–2022

ACADIA Pharmaceuticals Inc $2,579,610 42 payments

Who received the money Research payments · program years 2021–2022

Jbr Clinical Research Organisation paid for research $845,961 9 payments
Endeavor Clinical Trials Of San Antonio Tx Organisation paid for research $694,451 11 payments
Anaheim Clinical Trials (Act) Organisation paid for research $686,600 11 payments
Chesapeake Research Group LLC Organisation paid for research $345,599 10 payments
Arizona Research Center Organisation paid for research $7,000 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.